Seeking Alpha

J. Sobes'  Instablog

J. Sobes
Send Message
A recent graduate from the University of Connecticut (2012) with a BA in Communication Sciences. Previous experience includes working in Investment Banking with a focus on mezzanine financing, particularly for distressed companies performing debt restructuring, reverse mergers, and... More
  • This Healthcare Stock Is Oversold! 0 comments
    Jun 17, 2012 3:46 PM | about stocks: MAKO

    In the United States the healthcare industry has been under a lot of stress and, subsequently, a lot of change. Hopefully it's instinct for you to see that with change comes the opportunity to profit and that anyone whose anyone should be focusing on this industry right now. That's why I've been following MAKO Surgical these past couple months from a growth investor's perspective.

    MAKO is a company that began by offering a revolutionary robotics and implant system that helps facilitate partial knee surgery in a less invasive manner than what was currently on the market. What their technology does is basically offer a the opportunity for a surgeon to conduct a knee surgery with less trauma and recovery time, something that has an easy and obvious selling point for investors. Recently they've expanded their product line to assist in hip-implant procedures as well, a market that is valued at around $700M to $1B depending on whose estimates you are using.

    Financially, MAKO is a very sound company. Their market cap is at about a billion with no long-term debt. Quarterly revenues have been averaging around $22M this past year. While still somewhat distant from being profitable, about a -$10M net loss as of September's quarter, -$5M loss from December's, the company slid back on net profitability with a recent quarterly net loss of around $10M. As of their earnings release and this news of the recent quarter's loss MAKO lost almost 50% of it's value overnight and is currently trading in the $23-$25 range. That is why we believe that it is a solid buy.

    As with most growth stories this news seems to have obviously sent investors panicking and flurrying away from a solid growth stock with little fundamental changes. A quick financial analysis reveals that their loss was due to slightly less than expected revenue while most expenses stayed consistent with the past. The contrarian could always argue that this could mean the company has hit a wall and the technology simply isn't able to deeply penetrate the market but it is easy to find holes in this view. MAKO's technology has been implemented consistently across many hospitals in the US, and once implemented it is consistently being used. The increasing number of surgeries that this company has been supporting, along with their recent adjustment to market demand by also applying their technology to hip-replacement surgeries, should support demand for the company's products in the future. Additionally, their first-mover advantage against companies such as Zimmer Holdings and Stryker are very powerful from a fundamental view.

    Analyst on Wall St. are also looking at the company in a newer light. Mostly pegged at 'market perform' or 'hold' before the selloff, MAKO is seeing a flurry of analyst upgrades to 'buy' and 'outperform.' With this analysis, and using GS's new revised price target of $36 per share, I believe this represents a buying opportunity for the savvy growth investor.

    Disclosure: I am long MAKO.

    Themes: Healthcare, JNJ, SYK Stocks: MAKO
Back To J. Sobes' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

  • Anyone have any information on how to anlayze Multi-Employer Pension Plans? Apparently a new hybrid model is coming out...
    Jan 25, 2013
  • Has anyone else been waiting 20+ hours for an article to be published? What gives?
    Jan 7, 2013
  • Anyone following this BlueMountain JPM story? A little confused as to what it means
    Jun 21, 2012
More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.